Work as Technical Officer, Technician - QA/QC, stem cell research in Christian Medical College
Post: Technical Officer, Technician
[adsense:336x280:8701650588]
The U.S. Food and Drug Administration approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. Genvoya is marketed by Gilead Sciences Inc.